FMR LLC cut its position in Prestige Consumer Healthcare Inc (NYSE:PBH) by 16.8% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 4,173,180 shares of the company’s stock after selling 840,128 shares during the period. FMR LLC owned about 8.06% of Prestige Consumer Healthcare worth $124,820,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Financial Gravity Wealth Inc. bought a new position in shares of Prestige Consumer Healthcare in the 1st quarter valued at about $50,000. Quadrant Capital Group LLC grew its holdings in shares of Prestige Consumer Healthcare by 2,979.3% during the 1st quarter. Quadrant Capital Group LLC now owns 1,786 shares of the company’s stock valued at $53,000 after purchasing an additional 1,728 shares during the last quarter. Captrust Financial Advisors grew its holdings in shares of Prestige Consumer Healthcare by 23.8% during the 4th quarter. Captrust Financial Advisors now owns 2,228 shares of the company’s stock valued at $69,000 after purchasing an additional 428 shares during the last quarter. Bailard Inc. bought a new stake in Prestige Consumer Healthcare during the 1st quarter worth approximately $245,000. Finally, Bbva Compass Bancshares Inc. grew its holdings in Prestige Consumer Healthcare by 26.8% during the 4th quarter. Bbva Compass Bancshares Inc. now owns 8,111 shares of the company’s stock worth $250,000 after acquiring an additional 1,715 shares during the last quarter.
NYSE PBH traded up $1.40 during trading on Thursday, hitting $32.57. 324,100 shares of the company’s stock traded hands, compared to its average volume of 500,493. The stock has a market capitalization of $1.58 billion, a PE ratio of 11.72, a price-to-earnings-growth ratio of 1.76 and a beta of 0.93. Prestige Consumer Healthcare Inc has a 12-month low of $26.25 and a 12-month high of $41.76. The company has a quick ratio of 1.43, a current ratio of 2.37 and a debt-to-equity ratio of 1.64. The business’s 50 day simple moving average is $30.85.
PBH has been the topic of a number of recent analyst reports. TheStreet downgraded shares of USD Partners from a “b-” rating to a “c+” rating in a research report on Friday, May 10th. CIBC reiterated a “hold” rating and set a $84.00 target price on shares of Prestige Consumer Healthcare in a research report on Monday, May 27th. ValuEngine downgraded shares of Intersect ENT from a “buy” rating to a “hold” rating in a report on Monday, July 8th. Finally, Zacks Investment Research downgraded shares of Hanger from a “hold” rating to a “sell” rating in a report on Tuesday, May 28th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and one has issued a buy rating to the company. Prestige Consumer Healthcare has a consensus rating of “Hold” and a consensus target price of $57.77.
About Prestige Consumer Healthcare
Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning.
Further Reading: What are the advantages of the Stochastic Momentum Index?
Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.